title: [Primary hepatic non-Hodgkin's lymphoma].
authors.forename: M D
authors.initials: MD
authors.lastname: De la Maya
authors.forename: R
authors.initials: R
authors.lastname: Escalante
authors.forename: A
authors.initials: A
authors.lastname: Torre
authors.forename: C
authors.initials: C
authors.lastname: Urdambidelus
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D007813:Laparotomy; D008113:Liver Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology* / Q000601:surgery; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology* / Q000601:surgery; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone